Standard
Glycated haemoglobin and the risk of cardiovascular disease, diabetes and all-cause mortality in the Copenhagen City Heart Study. / Eskesen, K; Jensen, M T; Galatius, S; Vestergaard, H; Hildebrandt, P; Marott, J L; Jensen, J S.
In:
Journal of Internal Medicine, Vol. 273, No. 1, 2013, p. 94-101.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Eskesen, K, Jensen, MT, Galatius, S
, Vestergaard, H, Hildebrandt, P, Marott, JL & Jensen, JS 2013, '
Glycated haemoglobin and the risk of cardiovascular disease, diabetes and all-cause mortality in the Copenhagen City Heart Study',
Journal of Internal Medicine, vol. 273, no. 1, pp. 94-101.
https://doi.org/10.1111/j.1365-2796.2012.02594.xAPA
Eskesen, K., Jensen, M. T., Galatius, S.
, Vestergaard, H., Hildebrandt, P., Marott, J. L., & Jensen, J. S. (2013).
Glycated haemoglobin and the risk of cardiovascular disease, diabetes and all-cause mortality in the Copenhagen City Heart Study.
Journal of Internal Medicine,
273(1), 94-101.
https://doi.org/10.1111/j.1365-2796.2012.02594.xVancouver
Eskesen K, Jensen MT, Galatius S
, Vestergaard H, Hildebrandt P, Marott JL et al.
Glycated haemoglobin and the risk of cardiovascular disease, diabetes and all-cause mortality in the Copenhagen City Heart Study.
Journal of Internal Medicine. 2013;273(1):94-101.
https://doi.org/10.1111/j.1365-2796.2012.02594.xAuthor
Eskesen, K ; Jensen, M T ; Galatius, S ; Vestergaard, H ; Hildebrandt, P ; Marott, J L ; Jensen, J S. / Glycated haemoglobin and the risk of cardiovascular disease, diabetes and all-cause mortality in the Copenhagen City Heart Study. In: Journal of Internal Medicine. 2013 ; Vol. 273, No. 1. pp. 94-101.
Bibtex
@article{18a0b7bc67544f22b7938d0a9079a098,
title = "Glycated haemoglobin and the risk of cardiovascular disease, diabetes and all-cause mortality in the Copenhagen City Heart Study",
abstract = "Individuals with diabetes mellitus (DM) have a considerably elevated risk of developing serious health problems including cardiovascular disease (CVD). Long-term elevated levels of blood glucose in nondiabetic individuals may also be associated with increased risk of CVD. The aim of this study was to investigate the relationships between glycated haemoglobin A(1c) (HbA(1c) ) and CVD, DM and all-cause mortality.",
author = "K Eskesen and Jensen, {M T} and S Galatius and H Vestergaard and P Hildebrandt and Marott, {J L} and Jensen, {J S}",
note = "{\circledC} 2012 The Association for the Publication of the Journal of Internal Medicine.",
year = "2013",
doi = "10.1111/j.1365-2796.2012.02594.x",
language = "English",
volume = "273",
pages = "94--101",
journal = "Acta Medica Scandinavica",
issn = "0955-7873",
publisher = "Wiley-Blackwell",
number = "1",
}
RIS
TY - JOUR
T1 - Glycated haemoglobin and the risk of cardiovascular disease, diabetes and all-cause mortality in the Copenhagen City Heart Study
AU - Eskesen, K
AU - Jensen, M T
AU - Galatius, S
AU - Vestergaard, H
AU - Hildebrandt, P
AU - Marott, J L
AU - Jensen, J S
N1 - © 2012 The Association for the Publication of the Journal of Internal Medicine.
PY - 2013
Y1 - 2013
N2 - Individuals with diabetes mellitus (DM) have a considerably elevated risk of developing serious health problems including cardiovascular disease (CVD). Long-term elevated levels of blood glucose in nondiabetic individuals may also be associated with increased risk of CVD. The aim of this study was to investigate the relationships between glycated haemoglobin A(1c) (HbA(1c) ) and CVD, DM and all-cause mortality.
AB - Individuals with diabetes mellitus (DM) have a considerably elevated risk of developing serious health problems including cardiovascular disease (CVD). Long-term elevated levels of blood glucose in nondiabetic individuals may also be associated with increased risk of CVD. The aim of this study was to investigate the relationships between glycated haemoglobin A(1c) (HbA(1c) ) and CVD, DM and all-cause mortality.
U2 - 10.1111/j.1365-2796.2012.02594.x
DO - 10.1111/j.1365-2796.2012.02594.x
M3 - Journal article
VL - 273
SP - 94
EP - 101
JO - Acta Medica Scandinavica
JF - Acta Medica Scandinavica
SN - 0955-7873
IS - 1
ER -
